
Sun Jae Yoo
Examiner (ID: 4021, Phone: (571)272-9074 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1622, 1609, 1626, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1172 |
| Pending Applications | 219 |
| Abandoned Applications | 564 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17376998
[patent_doc_number] => 11234987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Isoxazole compounds as inhibitors of heat shock proteins
[patent_app_type] => utility
[patent_app_number] => 16/528278
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25330
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16528278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/528278 | Isoxazole compounds as inhibitors of heat shock proteins | Jul 30, 2019 | Issued |
Array
(
[id] => 18869858
[patent_doc_number] => 11857638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Quinone-containing conjugates
[patent_app_type] => utility
[patent_app_number] => 16/523384
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20508
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523384 | Quinone-containing conjugates | Jul 25, 2019 | Issued |
Array
(
[id] => 18216483
[patent_doc_number] => 11591405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Cytotoxic and anti-mitotic compounds, and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/523942
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 41849
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523942 | Cytotoxic and anti-mitotic compounds, and methods of using the same | Jul 25, 2019 | Issued |
Array
(
[id] => 17266374
[patent_doc_number] => 11191778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Multifunctional linker technology containing an N4 group
[patent_app_type] => utility
[patent_app_number] => 16/523044
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 13752
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523044 | Multifunctional linker technology containing an N4 group | Jul 25, 2019 | Issued |
Array
(
[id] => 18216483
[patent_doc_number] => 11591405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Cytotoxic and anti-mitotic compounds, and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/523942
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 41849
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523942 | Cytotoxic and anti-mitotic compounds, and methods of using the same | Jul 25, 2019 | Issued |
Array
(
[id] => 19622331
[patent_doc_number] => 12161117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Agrochemical combinations
[patent_app_type] => utility
[patent_app_number] => 17/255778
[patent_app_country] => US
[patent_app_date] => 2019-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12339
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255778 | Agrochemical combinations | Jul 4, 2019 | Issued |
Array
(
[id] => 18040523
[patent_doc_number] => 20220384740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => LIGAND MEDIATED LUMINESCENCE ENHANCEMENT IN CYCLOMETALATED RHODIUM(III) COMPLEXES AND THEIR APPLICATIONS IN HIGHLY EFFICIENT ORGANIC LIGHT-EMITTING DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/624472
[patent_app_country] => US
[patent_app_date] => 2019-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624472
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624472 | LIGAND MEDIATED LUMINESCENCE ENHANCEMENT IN CYCLOMETALATED RHODIUM(III) COMPLEXES AND THEIR APPLICATIONS IN HIGHLY EFFICIENT ORGANIC LIGHT-EMITTING DEVICES | Jul 3, 2019 | Abandoned |
Array
(
[id] => 15435303
[patent_doc_number] => 20200031835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/502826
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502826 | Fused pyrazine derivatives as A2A / A2B inhibitors | Jul 2, 2019 | Issued |
Array
(
[id] => 18197300
[patent_doc_number] => 20230050819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/257417
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257417 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Jul 1, 2019 | Abandoned |
Array
(
[id] => 17050526
[patent_doc_number] => 20210259960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => FORMULATION CONTAINING EMRICASAN
[patent_app_type] => utility
[patent_app_number] => 17/253648
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253648 | FORMULATION CONTAINING EMRICASAN | Jun 27, 2019 | Abandoned |
Array
(
[id] => 17095281
[patent_doc_number] => 20210283072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => Methods of Treating Mitochondrial Dysfunction
[patent_app_type] => utility
[patent_app_number] => 17/255508
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255508
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255508 | Methods of Treating Mitochondrial Dysfunction | Jun 25, 2019 | Abandoned |
Array
(
[id] => 14993621
[patent_doc_number] => 20190315768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 16/451509
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16451509
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/451509 | Nitrated hydrocarbons, derivatives, and processes for their manufacture | Jun 24, 2019 | Issued |
Array
(
[id] => 16519408
[patent_doc_number] => 10870617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Method for preparing dialkyl dicarbonates using amine oxides
[patent_app_type] => utility
[patent_app_number] => 16/451532
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1989
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16451532
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/451532 | Method for preparing dialkyl dicarbonates using amine oxides | Jun 24, 2019 | Issued |
Array
(
[id] => 17982535
[patent_doc_number] => 20220348571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/254236
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 455
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254236 | DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES | Jun 24, 2019 | Abandoned |
Array
(
[id] => 19608851
[patent_doc_number] => 12157717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Compounds for the treatment of bovine or swine respiratory disease
[patent_app_type] => utility
[patent_app_number] => 17/253437
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40165
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253437 | Compounds for the treatment of bovine or swine respiratory disease | Jun 23, 2019 | Issued |
Array
(
[id] => 18057867
[patent_doc_number] => 20220388953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => COMPOUNDS WITH ANTIMICROBIAL ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/250178
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 372
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17250178
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/250178 | COMPOUNDS WITH ANTIMICROBIAL ACTIVITY | Jun 17, 2019 | Pending |
Array
(
[id] => 17050603
[patent_doc_number] => 20210260037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => MELANOCORTIN AGENTS FOR USE IN THE THERAPEUTIC TREATMENT OF MELANOMA, TUMORS OF THE GASTROINTESTINAL TRACT, AND THYROID CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 17/253883
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253883 | Melanocortin agents for use in the therapeutic treatment of melanoma, tumors of the gastrointestinal tract, and thyroid carcinoma | Jun 13, 2019 | Issued |
Array
(
[id] => 19310420
[patent_doc_number] => 12036214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Solid dispersion comprising an anticancer compound for improved solubility and efficacy
[patent_app_type] => utility
[patent_app_number] => 17/253193
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5743
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253193 | Solid dispersion comprising an anticancer compound for improved solubility and efficacy | Jun 13, 2019 | Issued |
Array
(
[id] => 16512833
[patent_doc_number] => 20200392091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => METHOD FOR THE SYNTHESIS OF 3-R-1,4,2-DIOXAZOL-5-ONES TECHNICAL FIELD
[patent_app_type] => utility
[patent_app_number] => 16/440584
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16440584
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/440584 | Method for the synthesis of 3-R-1,4,2-dioxazol-5-ones | Jun 12, 2019 | Issued |
Array
(
[id] => 17141629
[patent_doc_number] => 20210309641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => AMIDINES AND AMIDINE ANALOGS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION ANTIBIOTICS
[patent_app_type] => utility
[patent_app_number] => 17/251658
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251658
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251658 | Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics | Jun 12, 2019 | Issued |